All In MedTech

Device Trial Radar · NCT07655479

Rapid Impella Support and Escalation in Patients With Myocardial Infarction Associated Cardiogenic Shock and Persistent Need of Hemodynamic Support

Rapid Impella Support and Escalation Trial

Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

115

Planned (sponsor's estimate)

Start

Apr 23, 2026

Primary completion

Oct 2028

Study completion Oct 2028

Sponsor

Lead sponsor
University Hospital of CologneAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Johnson & Johnson
First posted
Jun 17, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 77 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of this trial is to evaluate whether a structured and time-optimized escalation strategy from a transfemoral microaxial flow-pump (Impella CP™) to the Impella 5.5™ microaxial flow-pump is associated with improved clinical outcomes and fewer adverse events in patients with cardiogenic shock due to acute myocardial infarction

Conditions

  • Cardiogenic Shock Post Myocardial Infarction

Interventions

  • Escalation to more capable microaxial flow-pump (Impella 5.5)Device

    Rapid escalation from Impella CP to Impella 5.5 within 24 hours post revascularization

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Vasoactive Hemodynamic Score (VHS) < 5Time frame: 48 hours post revascularization

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • University Hospital Cologne

    Cologne, Germany · Recruiting

  • University Hospital Düsseldorf

    Düsseldorf, North Rhine-Westphalia, Germany · Recruiting

  • University Hospital Schleswig-Holstein, Campus Kiel

    Kiel, Schleswig-Holstein, Germany · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.